Brokerages Set Guardant Health, Inc. (NASDAQ:GH) Price Target at $48.21
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Buy” from the nineteen research firms that are covering the company, MarketBeat reports. Nineteen equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued a report on the stock […]
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Buy” from the nineteen research firms that are covering the company, MarketBeat reports. Nineteen equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued a report on the stock […]
